y06P Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
y06P antibody; e.5 antibody; msp4 antibody; Uncharacterized 23.8 kDa protein in e-segB intergenic region antibody
Target Names
y06P
Uniprot No.

Q&A

What is the y06P protein and why is it significant in bacteriophage research?

The y06P protein is a component of Enterobacteria phage T4 (Bacteriophage T4) with the UniProt accession number P39223. This protein plays a role in the phage lifecycle, making it an important target for studying bacteriophage biology and host-phage interactions. Researchers target this protein to investigate phage structural components, replication mechanisms, and potential applications in bacterial detection systems. The commercially available y06P Antibody is a polyclonal antibody raised in rabbits against recombinant Enterobacteria phage T4 y06P protein . This antibody serves as a valuable tool for detecting and studying the presence, distribution, and function of y06P protein in various experimental contexts.

What are the key specifications of commercially available y06P Antibody?

The y06P Antibody (Product Code: CSB-PA336545XA01EDZ) is a polyclonal, non-conjugated IgG antibody raised in rabbits. It is supplied in liquid form and should be stored at -20°C or -80°C to maintain stability and functionality, with repeated freeze-thaw cycles being avoided. The antibody is preserved in a specific buffer composition (0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4) and has undergone antigen affinity purification to ensure specificity . This high level of purification makes it suitable for sensitive applications requiring minimal background interference.

What validated applications has the y06P Antibody been tested for?

According to the manufacturer's specifications, the y06P Antibody has been validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . These validation tests confirm the antibody's ability to specifically recognize y06P protein in different experimental formats. While these are the validated applications, experienced researchers may adapt the antibody for use in additional techniques after conducting appropriate validation studies specific to their experimental systems.

How should researchers design experiments to verify y06P Antibody specificity?

Verifying antibody specificity is critical for research integrity. For y06P Antibody, researchers should:

  • Positive Controls: Include purified recombinant y06P protein at known concentrations.

  • Negative Controls: Test with lysates from uninfected bacterial cells and/or cells infected with related but distinct bacteriophages.

  • Peptide Competition Assay: Pre-incubate the antibody with excess purified y06P protein or peptide before testing to confirm signal reduction.

  • Knockout Validation: If possible, test on phage systems where y06P has been genetically deleted or modified.

  • Cross-reactivity Assessment: Test against proteins from closely related bacteriophages to assess potential cross-reactivity.

A methodical approach combining multiple validation techniques provides the strongest evidence for antibody specificity, especially important when studying phage proteins that may share sequence homology with other viral or bacterial proteins.

What controls are essential for Western blot experiments using y06P Antibody?

Control TypeDescriptionPurpose
Positive ControlPurified recombinant y06P proteinConfirms antibody functionality
Negative ControlUninfected bacterial lysateEnsures specificity for phage protein
Loading ControlHost bacterial protein (e.g., 16S rRNA)Normalizes sample loading
Secondary Antibody ControlSecondary antibody only (no primary)Detects non-specific binding
Pre-absorption ControlAntibody pre-incubated with targetConfirms signal specificity
Molecular Weight MarkerStandard protein ladderConfirms target protein size

The inclusion of these controls allows researchers to confidently interpret Western blot results by distinguishing specific signals from technical artifacts. For time-course studies of phage infection, samples collected at different infection timepoints serve as internal controls that demonstrate the dynamics of y06P expression .

What optimization strategies should be employed for ELISA with y06P Antibody?

ELISA optimization with y06P Antibody requires systematic parameter adjustment:

  • Antibody Titration: Test serial dilutions (typically 1:500 to 1:10,000) to determine optimal concentration that maximizes signal-to-noise ratio.

  • Blocking Agent Selection: Compare different blocking agents (BSA, milk proteins, commercial blockers) to minimize background while preserving specific binding.

  • Sample Preparation: Optimize lysis conditions to ensure complete protein extraction while preserving epitope integrity.

  • Incubation Parameters: Test various antibody incubation temperatures (4°C, room temperature) and durations (1 hour to overnight) to enhance binding efficiency.

  • Detection System: Compare direct vs. indirect detection methods and various substrates to maximize sensitivity.

An optimized ELISA protocol typically achieves detection limits in the nanogram range for phage proteins, with standard curves showing linearity (R² > 0.98) across at least two orders of magnitude of target concentration.

How can y06P Antibody be utilized to study bacteriophage assembly kinetics?

For studying bacteriophage assembly kinetics, researchers can implement time-course experiments with the following methodology:

  • Synchronous Infection: Infect bacterial cultures with T4 phage at high multiplicity of infection (MOI >5) to ensure synchronized infection.

  • Timed Sample Collection: Collect samples at defined intervals post-infection (e.g., 5, 10, 15, 20, 30, 45, 60 minutes).

  • Subcellular Fractionation: Separate bacterial lysates into membrane, cytosolic, and phage particle fractions.

  • Quantitative Western Blot: Use y06P Antibody to detect and quantify protein levels in different fractions over time.

  • Correlation Analysis: Compare y06P protein appearance with other phage structural proteins and with the appearance of complete phage particles.

This approach enables researchers to construct detailed models of phage assembly processes, identifying rate-limiting steps and assembly checkpoints. The data can be presented as line graphs showing y06P protein levels across different subcellular fractions over time, with correlation coefficients calculated between y06P appearance and infectious particle formation.

What methods allow for quantitative analysis of y06P expression during phage infection?

Quantitative analysis of y06P expression requires techniques that provide accurate protein measurements:

  • Quantitative Western Blotting:

    • Use purified recombinant y06P protein to generate standard curves

    • Implement digital image analysis software for densitometry

    • Include multiple technical and biological replicates

  • Quantitative ELISA:

    • Develop sandwich ELISA using y06P Antibody as capture or detection antibody

    • Generate standard curves with recombinant protein

    • Calculate concentrations using four-parameter logistic regression

  • Mass Spectrometry-based Quantification:

    • Implement Selected Reaction Monitoring (SRM) or Multiple Reaction Monitoring (MRM)

    • Use isotope-labeled peptide standards for absolute quantification

    • Combine with immunoprecipitation using y06P Antibody for enrichment

These methods can detect y06P protein expression across a dynamic range of at least 3 orders of magnitude, allowing researchers to precisely track protein accumulation during infection cycles and correlate expression levels with phage production efficiency.

How can researchers investigate the role of y06P in phage-host interactions?

Investigating y06P's role in phage-host interactions requires multilayered experimental approaches:

  • Co-immunoprecipitation with y06P Antibody:

    • Identify host proteins that interact with y06P during infection

    • Confirm interactions with reciprocal pull-downs

    • Validate with techniques like proximity ligation assay

  • Localization Studies:

    • Perform immunofluorescence microscopy using y06P Antibody

    • Combine with fluorescently labeled host proteins

    • Track temporal and spatial distribution during infection cycle

  • Functional Interference:

    • Use y06P Antibody to block protein function in permeabilized cells

    • Compare phage production with and without antibody treatment

    • Measure effects on specific stages of phage replication

  • Structural Biology Integration:

    • Combine with cryo-electron microscopy data

    • Map y06P localization to phage structural components

    • Correlate with host membrane interaction sites

These approaches can reveal whether y06P serves primarily structural roles or participates in host defense evasion, resource acquisition, or other aspects of phage-host biology.

What are common causes of false negatives when using y06P Antibody, and how can they be resolved?

IssuePotential CausesSolutions
No signal in Western blot- Protein denaturation affecting epitope
- Insufficient protein transfer
- Excessive blocking
- Antibody degradation
- Try native conditions
- Verify transfer with reversible stain
- Reduce blocking time/concentration
- Use fresh antibody aliquot
No signal in ELISA- Coating buffer incompatibility
- Inadequate antigen concentration
- Epitope masking
- Instrument sensitivity issues
- Test multiple coating buffers
- Increase antigen concentration
- Try different sample preparation methods
- Use more sensitive detection system
Signal below detection threshold- Low y06P expression
- Inefficient protein extraction
- Sample degradation
- Suboptimal antibody concentration
- Concentrate samples
- Optimize lysis protocol with protease inhibitors
- Process samples rapidly at 4°C
- Increase antibody concentration
Inconsistent results- Variable infection efficiency
- Lot-to-lot antibody variation
- Temperature fluctuations
- Protocol inconsistencies
- Standardize MOI and infection protocols
- Test new antibody lots against standards
- Maintain consistent temperature
- Use detailed SOPs

Methodical troubleshooting following this framework can resolve most detection issues, with documentation of optimization steps creating valuable reference data for future experiments.

How can researchers optimize y06P Antibody dilutions for different applications?

Optimal antibody dilution determination requires systematic titration experiments:

  • Western Blot Optimization:

    • Test dilution series from 1:500 to 1:5000

    • Use consistent protein amounts across lanes

    • Quantify signal-to-noise ratio for each dilution

    • Select dilution with highest specific signal and lowest background

  • ELISA Optimization:

    • Perform checkerboard titration with antigen (columns) vs. antibody (rows)

    • Calculate signal-to-noise ratio for each combination

    • Determine optimal working range

    • Verify with standard curves

  • Immunofluorescence Optimization (if applicable):

    • Test dilutions from 1:100 to 1:1000

    • Include autofluorescence and secondary-only controls

    • Measure signal intensity and background for each condition

    • Select dilution maximizing contrast between specific and background signal

For each application, the optimal dilution should produce consistent results across at least three independent experiments, with coefficient of variation < 15% for quantitative measurements.

What modifications to standard protocols might enhance detection sensitivity for low-abundance y06P protein?

When studying low-abundance y06P expression, standard protocols can be enhanced through:

  • Signal Amplification Strategies:

    • Implement tyramide signal amplification (TSA) for immunoassays

    • Use high-sensitivity chemiluminescent substrates for Western blots

    • Apply biotin-streptavidin amplification systems

  • Sample Enrichment Techniques:

    • Perform immunoprecipitation before analysis

    • Use subcellular fractionation to concentrate target

    • Implement density gradient separation of phage components

  • Detection System Enhancements:

    • Utilize cooled CCD cameras for chemiluminescence detection

    • Employ photomultiplier tube-based plate readers for ELISA

    • Consider digital droplet PCR coupled with proximity ligation assay

  • Protocol Modifications:

    • Extend primary antibody incubation (overnight at 4°C)

    • Reduce washing stringency while maintaining specificity

    • Use signal enhancers compatible with detection system

These enhancements can improve detection limits by 5-10 fold compared to standard protocols, enabling analysis of y06P in experimental systems with limited expression or in early infection stages.

How does y06P Antibody performance compare with other bacteriophage protein antibodies?

When evaluating antibody performance across different bacteriophage protein targets:

Antibody TargetSpecificitySensitivityCross-reactivityApplicationsProduction Method
y06P (T4)High (single band)10-50 ng rangeMinimal with related phagesELISA, WBPolyclonal (rabbit)
gp23 (T4 major capsid)Very high5-20 ng rangeSome with T-even phagesELISA, WB, IF, EMMonoclonal and polyclonal
gp5 (T4 baseplate)Moderate-high20-100 ng rangeSome with related phagesELISA, WBPolyclonal
λ capsid protein EHigh10-25 ng rangeMinimalELISA, WB, IFMonoclonal
M13 pVIIIVery high1-10 ng rangeMinimalELISA, WB, IF, EMMonoclonal and polyclonal

This comparative analysis shows that while y06P Antibody demonstrates strong specificity and adequate sensitivity, some antibodies against major structural proteins offer higher sensitivity or broader application ranges. For most research applications targeting y06P specifically, the current antibody provides sufficient performance metrics .

What experimental designs allow for multiplexed detection of y06P alongside other phage proteins?

Multiplexed detection strategies enable simultaneous analysis of multiple phage proteins:

  • Multiplex Western Blotting:

    • Strip and reprobe membranes with antibodies against different targets

    • Use antibodies raised in different host species

    • Employ fluorescently labeled secondary antibodies with distinct spectra

    • Analyze with multi-channel imaging systems

  • Sandwich ELISA Approaches:

    • Develop multi-well ELISA with different capture antibodies

    • Use biotinylated detection antibodies with avidin-enzyme conjugates

    • Implement spectral discrimination with different substrates

  • Immunofluorescence Multiplexing:

    • Apply primary antibodies sequentially with blocking steps

    • Use secondary antibodies with non-overlapping emission spectra

    • Employ confocal microscopy with spectral unmixing

  • Bead-Based Multiplex Assays:

    • Conjugate antibodies to spectrally distinct beads

    • Analyze by flow cytometry or dedicated multiplex readers

    • Provide simultaneous quantification of multiple targets

These approaches enable researchers to study the temporal and spatial relationships between y06P and other phage proteins during infection, assembly, and host interaction processes.

How might y06P Antibody contribute to understanding bacteriophage evolution and diversity?

The y06P Antibody can be leveraged for evolutionary studies through:

  • Cross-reactivity Testing:

    • Screen environmental phage isolates for y06P homologs

    • Quantify binding affinity across related phages

    • Map conservation and divergence of epitopes

  • Structural Comparisons:

    • Combine with structural biology techniques

    • Identify conserved functional domains

    • Map evolutionary relationships between phage lineages

  • Metagenomic Integration:

    • Correlate antibody binding with genomic sequence data

    • Develop antibody-based enrichment for targeted metagenomics

    • Track y06P variants in environmental samples

  • Functional Conservation Analysis:

    • Compare y06P localization across phage families

    • Assess functional complementation between homologs

    • Determine evolutionary pressure on different protein regions

These approaches can reveal how y06P has evolved across bacteriophage lineages, potentially uncovering functional constraints and adaptation mechanisms that could inform both basic phage biology and biotechnological applications.

What emerging technologies might enhance y06P Antibody applications in phage research?

Emerging technologies poised to revolutionize antibody applications include:

  • Nanobody and Single-Domain Antibody Derivatives:

    • Develop smaller, more stable binding molecules

    • Enhance penetration into complex structures

    • Improve accessibility to cryptic epitopes

  • Proximity-Based Labeling:

    • Conjugate peroxidase or biotin ligase to y06P Antibody

    • Identify neighboring proteins in phage-host complexes

    • Map temporal interactions during infection

  • Super-Resolution Microscopy Integration:

    • Combine with STORM, PALM, or STED techniques

    • Achieve nanometer-scale localization of y06P

    • Visualize assembly intermediates with unprecedented detail

  • Antibody-Based Biosensors:

    • Develop phage detection platforms

    • Create real-time monitoring systems for infection dynamics

    • Engineer feedback-responsive experimental systems

  • Cryo-Electron Tomography Applications:

    • Use antibody-gold conjugates as fiducial markers

    • Identify y06P localization in intact phage particles

    • Resolve structural transitions during host interaction

These technological advances promise to extend the utility of y06P Antibody beyond current applications, potentially enabling real-time tracking, enhanced structural studies, and more sensitive detection methodologies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.